2021
DOI: 10.1111/jdv.17257
|View full text |Cite
|
Sign up to set email alerts
|

A new virtual inpatient dermatology electronic referral service: a timely solution in the COVID‐19 pandemic and beyond?

Abstract: Table 1 Benefits and limitations of a new virtual electronic inpatient dermatology referral service versus a paper and face-to-face (FTF) system Benefits Limitations Faster access to dermatology opinions for inpatients Access to photographs rate-limiting step All essential clinical details fully included in e-referral Accuracy of diagnosis reliant on quality of photographs Automatic paper trail (no referrals physically misplaced) Need to convert to FTF for some patients if diagnosis unclear and/or biopsy requi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…The individual attitude toward teledermatology has favorably changed within the last 10 years, as reported in a recent survey of British dermatologists [ 5 ]. During the COVID-19 pandemic, remote consultations have markedly increased in importance [ 6 ]. However, a prerequisite for widespread adoption of telemedicine is that it must favorably compete with in-person consultations on several objective measures, including effectiveness [ 7 , 8 ], availability [ 9 , 10 ], and costs [ 11 ].…”
Section: Introductionmentioning
confidence: 99%
“…The individual attitude toward teledermatology has favorably changed within the last 10 years, as reported in a recent survey of British dermatologists [ 5 ]. During the COVID-19 pandemic, remote consultations have markedly increased in importance [ 6 ]. However, a prerequisite for widespread adoption of telemedicine is that it must favorably compete with in-person consultations on several objective measures, including effectiveness [ 7 , 8 ], availability [ 9 , 10 ], and costs [ 11 ].…”
Section: Introductionmentioning
confidence: 99%